Inter-conversion of neuregulin2 full and partial agonists for ErbB4
Authors:
- 1 December 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 364 (2) , 351-357
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Purdue University (F33CA085049, R01CA114209, R21CA080770, R21CA089274, T32GM008737)
This publication has 23 references indexed in Scilit:
- Activation of a Nuclear Factor κB/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer CellsMolecular Cancer Research, 2007
- Signaling through ERBB receptors: Multiple layers of diversity and controlCellular Signalling, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2β and agonist-independent coupling with downstream signalling eventsBiochemical Journal, 2006
- Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer InterfaceMolecular and Cellular Biology, 2005
- Phe45 of NRG2β is critical for the affinity of NRG2β for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2βGrowth Factors, 2005
- Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activationOncogene, 2002
- Cloning and Biological Activity of Epigen, a Novel Member of the Epidermal Growth Factor SuperfamilyJournal of Biological Chemistry, 2001
- The role of EGF-related peptides in tumor growthFrontiers in Bioscience-Landmark, 2001
- Ligand Discrimination in Signaling through an ErbB4 Receptor HomodimerJournal of Biological Chemistry, 2000